Advanced
Bioactive Peptides in Milk and Dairy Products: A Review
Bioactive Peptides in Milk and Dairy Products: A Review
Food Science of Animal Resources. 2015. Dec, 35(6): 831-840
Copyright © 2015, Korean Society for Food Science of Animal Resources
This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • Received : July 10, 2015
  • Accepted : November 10, 2015
  • Published : December 31, 2015
Download
PDF
e-PUB
PubReader
PPT
Export by style
Article
Author
Metrics
Cited by
TagCloud
About the Authors
Young Woo, Park
Georgia Small Ruminant Research & Extension Center, Fort Valley State University, Fort Valley, GA 31030, and Adjunct Professor Emeritus, Department of Food Science & Technology, University of Georgia, Athens, GA, 30602, USA
Parky@fvsu.edu
Myoung Soo, Nam
Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University, Daejeon 34134, Korea

Abstract
Functionally and physiologically active peptides are produced from several food proteins during gastrointestinal digestion and fermentation of food materials with lactic acid bacteria. Once bioactive peptides (BPs) are liberated, they exhibit a wide variety of physiological functions in the human body such as gastrointestinal, cardiovascular, immune, endocrine, and nervous systems. These functionalities of the peptides in human health and physiology include antihypertensive, antimicrobial, antioxidative, antithrombotic, opioid, anti-appetizing, immunomodulatory and mineral-binding activities. Most of the bioactivities of milk proteins are latent, being absent or incomplete in the original native protein, but full activities are manifested upon proteolytic digestion to release and activate encrypted bioactive peptides from the original protein. Bioactive peptides have been identified within the amino acid sequences of native milk proteins. Due to their physiological and physico-chemical versatility, milk peptides are regarded as greatly important components for health promoting foods or pharmaceutical applications. Milk and colostrum of bovine and other dairy species are considered as the most important source of natural bioactive components. Over the past a few decades, major advances and developments have been achieved on the science, technology and commercial applications of bioactive components which are present naturally in the milk. Although the majority of published works are associated with the search of bioactive peptides in bovine milk samples, some of them are involved in the investigation of ovine or caprine milk. The advent of functional foods has been facilitated by increasing scientific knowledge about the metabolic and genomic effects of diet and specific dietary components on human health.
Keywords
Introduction
Milk of all mammalian species contains a heterogeneous mixture of lacteal secretion which contains numerous components which exhibit a wide variety of chemical and functional activities. These diversified composition and functionality of milk can be found in even protein components alone. Proteins constitute a myriad of serum and glandular-derived compounds which are different in molecular size, concentration and functionality ( Regester , 1997 ). The traditional and contemporary view of the role of milk has been markedly expanded beyond the horizon of nutritional subsistence of infants ( Gobbetti , 2007 ; Park, 2009a ). Milk has been more than a source of nutrients to any neonate of mammalian species, as well as for growth of children and nourishment of adult humans ( Park, 2009b ). It contains a wide range of proteins that provide protection against enteropathogens or are essential for the manufacture and characteristic nature of certain dairy products ( Korhonen and Pihlanto-Leppälä, 2004 ).
Recent studies indicate that milk furnishes a broad range of biologically active compounds that guard neonates and adults against pathogens and illnesses, such as immunoglobulins, antibacterial peptides, antimicrobial proteins, oligosaccharides, lipids, besides many other components at low concentrations, so-called “minor” components, but with considerable potential benefits, illustrated in Fig. 1 ( Park, 2009b ). Thus, beyond nutritional values of milk, milk-born biologically active compounds such as caseins, whey proteins and other minor constituents exhibit important physiological and biochemical functions that have crucial impacts on human metabolism and health ( Gobbetti , 2007 ; Korhonen and Pihlanto-Leppala, 2004 ; Park, 2009a ; Schanbacher , 1998 ). Bioactivity of milk components have been categorized as four major areas: (1) gastrointestinal development, activity, and function; (2) immunological development and function; (3) infant development; and (4) microbial activity, including antibiotic and probiotic action ( Gobbetti , 2007 ).
PPT Slide
Lager Image
Major bioactive functional compounds derived from milk (Park, 2009b).
Recently, fractionation and marketing of bioactive milk ingredients have emerged as a new lucrative sector for dairy industries and specialized bio-industries. Many of these components are being exploited for both dairy and non-dairy food formulations and even pharmaceuticals ( Korhonen and Pihlanto, 2007a ; Krissansen, 2007 ; Playne , 2003 ; Shah, 2000 ). The dairy industry has played a leading role in the development of functional foods and also has already commercialized these products. Those products have enhanced bioactive functions in human health including the immune system, reduce elevated blood pressure, combat gastrointestinal infections, help control body weight and prevent osteoporosis ( FitzGerald , 2004 ; Hartmann and Meisel, 2007 ; Korhonen and Marnila, 2006 ).
The objectives of this paper are to: (1) review the current knowledge on bioactive peptides derived from milk of major species concerning various forms of naturally occurring bioactive compounds, their physiological, biochemical and nutritional functionalities in human health, and (2) elucidate some recent studies on potential applications and development of functional foods using bioactive peptides and components in bovine milk as well as in other species milk.
Functionalities of Bioactive Peptides in Milk and Dairy Products
Numerous studies have been reported on functional properties of bioactive components in milk and dairy products especially in human and bovine milk, although more people drink the milk of goats than that of any other single species worldwide ( Haenlein and Caccese, 1984 ; Park, 1990 , 2006 ). On the other hand, the study of these bioactive components in milks has been difficult, because of the low concentrations of certain very potent agents in milks, their biochemical complexities, the need to develop specific methods to quantify certain factors due to their particular forms in milks, the compartmentalization of some of the agents, and the dynamic effects of lactation length and other maternal factors on concentrations or functions of the components of the systems ( Goldman and Goldblum, 1995 ; Park, 2009a ).
Among those bioactive constituents in milk and dairy products, bioactive peptides (BPs) are the most studied components in this regard. BPs have been defined as specific protein fragments that have a positive influence on physiological and metabolic functions or condition of the body and may have ultimate beneficial effects on human health ( Kitts and Weiler, 2003 ). BPs can be delivered to the consumers in conventional foods, dietary supplements, functional foods, or medical foods. These bioactive peptides possess very important biological activities and functionalities, including antimicrobial, antihypertensive, antioxidative, anticytotoxic, immunomodulatory, opioid, and mineral-carrying activities.
The bioactive peptides derived from a variety of dietary proteins have been reviewed by many researchers ( Clare, 2003 ; FitzGerald and Meisel, 2003 ; Li , 2004 ). BPs are inactive within the sequence of the parent protein, and they can be released in three ways: (i) through hydrolysis by digestive enzymes, (ii) through hydrolysis of proteins by proteolytic microorganisms, and (iii) through the action of proteolytic enzymes derived from microorganisms or plants ( Korhonen and Pihlanto, 2007b ). A schematic representation of formation of bioactive peptides from major milk proteins is presented in Fig. 2 .
PPT Slide
Lager Image
Formation of bioactive peptides from major milk proteins (Korhonen and Pihlanto, 2007b).
Many scientists have conducted a variety of research and demonstrated many biologically active compounds especially in BPs in different dairy species such as bovine, ovine and caprine milk ( Table 1 and 2 ). The proven functionalities of milk bioactive peptides are summarized as follows:
Major biologically active milk components and their functions1
PPT Slide
Lager Image
1 Adapted from Schanbacher et al. (1998), Meisel (1998), and Clare and Swaisgood (2000), Park (2009b)
Sequence of bioactive peptides derived from ovine and caprine milk proteins
PPT Slide
Lager Image
Park et al. (2007)
- Antihypertensive peptides
The angiotensin is one of two polypeptide hormones and a powerful vasoconstrictor that functions in the body by controlling arterial blood pressure through the contraction of smooth muscles of the blood vessel ( Park, 2009a ). Angiotensin converting enzyme (ACE)-inhibitory peptide blocks the conversion of angiotensin I to angiotensin II. The ACE causes elevation of blood pressure by converting angiotensin-I to the potent vasoconstrictor, angiotensin-II, and by degrading bradykinin, a vasodilatory peptide, and enkephalins ( Petrillo and Ondetti, 1982 ).
As shown in Table 1 , several ACE-inhibitory peptides were identified by in vitro enzymatic digestion of milk proteins or chemical synthesis of peptide analogs ( Gobbetti , 2004 ). The ACE-inhibitors derived from milk proteins are attributed to different fragments of casein, named casokinins ( Meisel and Schlimme, 1994 ), or whey proteins, named lactokinins ( FitzGerald and Meisel, 2000 ).
- Antioxidative peptides
Peptides derived from αs-casein have free radical-scavenging activity and inhibit enzymatic and nonenzymatic lipid peroxidation ( Rival , 2001 ; Suetsuna , 2000 ). Proteolytic enzymes can release antioxidative peptides from caseins, soybean and gelatine by enzymatic hydrolysis (Korhonen and Pihlanto, 2003).
Low temperature-processed whey protein contained high levels of specific dipeptides (glutamylcysteine) ( Bounous and Gold, 1991 ). These dipeptides can promote the synthesis of glutathione, which is an important antioxidant for cellular protection and repair processes.
Apart from milk peptides, Byun (2009) analyzed fish protein hydrolysates from the rotifer Brachionus rotundiformis , using different proteases (Alcalase, α-chymotrypsin, Neutrase, papain, pepsin and trypsin), and found antioxidant peptides from the hydrolysates. Antioxidant activities of hydrolysates were evaluated using DPPH radical scavenging activity.
- Antithrombotic peptides
These peptides reduce or inhibit the formation of blood clots. Caseinomacropeptide (CMP) is a peptide split from k-casein when the milk protein is coagulated by rennin enzyme. This CMP has functions of inhibiting the aggregation of blood platelets and binding of the human fibrinogen γ-chain to platelet surface fibrinogen receptors ( Fiat , 1993 ). There are two reported antithrombotic peptides, derived from human and bovine k-caseinoglycopeptides, which were identified in the plasma of 5-d-old newborns after breast-feeding and feeding cow milk based formula ( Chabance , 1998 ).
Casoplatelin, peptide derived from κ-CN ( Table 1 ), exhibited influence on platelet function and inhibited both the aggregation of ADP-activated platelets and the binding of human fibrinogen γ-chain to its receptor region on the platelets surface ( Jolles , 1986 ). Sheep caseins derived κ-caseinoglycopeptide (106-171) reduced thrombinand collagen-induced platelet aggregation in a dose dependent manner ( Qian , 1995 ).
- Hypocholesterolemic peptides
Iwami (1986) reported that a peptide having high bile acid-binding capacity can inhibit the reabsorption of bile acid in the ileum, whereby it can decrease the blood cholesterol level. A novel peptide (Ile-Ile-Ala-Glu-Lys) from tryptichydrolysate of β-lactoglobulin showed hypocholesterolemic effect ( Nagoaka , 2001 ).
The serum cholesterol-lowering activity is directly influenced by the degree of fecal steroid excretion (Nagata et al. , 1982). Cholesterol is become soluble in bile salt-mixed micelles and then absorbed ( Wilson and Rudel, 1994 ). Cholesterol absorption was suppressed by this peptide in Caco-2 cells in vitro, and also the peptide elicited hypocholesterolemic activity in vivo in rats after oral administration of the peptide solution. The mechanism of the hypocholesterolemic effect by these peptides has not been delineated ( Korhonen and Pihlanto, 2007b ), while four bioactive peptides were identified in the hydrolysate which corresponded to β-lactoglobulin f9-14, f41-60, f71-75, and f142-146.
- Opioid peptides
An opioid is any chemical such as morphine that resembles opiates in its pharmacological effects. Opioids are defined as peptides (i.e., enkephalins) which have an affinity for an opiate receptor and opiate-like effects, inhibited by naloxone ( Gobbetti , 2007 ). As shown in Table 1 , many opioid peptides have been identified. Opioid peptides are opioid receptor ligands with agonistic or antagonistic activities ( Park, 2009a ).
The α s1 -casein-exorphin (α s1 -CN f90-96), β-casomorphins-7 and -5 (β-CN f60-66 and f60-64, respectively), and lactorphins (α-lactalbumin f50-53 and β-lactoglobulin f102-105) act as opioid agonists, whereas casoxins (i.e., k-CN f35-42, f58-61, and f25-34) act as opioid antagonists ( Gobbetti , 2007 ; Meisel and FitzGerald, 2000 ). β-Casomorphins were found in the analoguous position of the natural proteins in cow, sheep, water buffalo, and human β-CN ( Meisel and Schlimme, 1996 ).
In all endogenous and exogenous opioid peptides, the common structural feature of these peptides is the presence of a Tyr residue at the amino terminal end (except for α s1 -CN-exorphin, casoxin 6, and lactoferroxin B and C) and of another aromatic residue, Phe or Tyr, in 3rd or 4th position ( Gobbetti , 2007 ). The hydrolysis of Lactobacillus GG fermented UHT milk by the pepsin/trypsin has shown to release several opioid peptides from α s1 - and β-CN, and α-lactalbumin ( Rokka , 1997 ).
- Antiappetizing peptides
These peptides have functions of suppressing the appetite, whereby they prevent gaining weight and obesity. Zhang and Beynen (1993) reported that the total whey protein in the diet has been associated with a lowering of LDL cholesterol, and also related to the increased release of an appetite-suppressing hormone, cholecystokinin.
The bioactive functions of total whey protein may arise from the combinations of active whey protein fractions or amino acid sequences. Regester (1997) suggested that this physiological role of total whey protein has a great potential for processed whey products in development of new and lucrative health food markets as functional food ingredients.
- Antimicrobial peptides
These peptides have bacterial membrane-lytic activities which disrupt normal membrane permeability. The total antibacterial effect in milk is greater than the sum of individual immunoglobulin and nonimmunoglobulin such as lactoferrin, lactoferricins, lactoperoxidase, lysozyme, lactenin, casecudubs, etc. ( Gobbetti , 2007 ; Park, 2009a ).
- Peptides exhibiting antimicrobial activities have been isolated and purified from several
Bovine milk protein hydrolysates, edible plants, fish and eggs ( Clare , 2003 ; Gobbetti , 2004 ). Among antimicrobial peptides, the lactoferricins are studied the most, which are derived from bovine and human lactoferrin ( Kitts and Weiler 2003 ; Wakabayashi , 2003 ). Lactoferricins have been shown to have antimicrobial activity against various Gram-positive and -negative bacteria, yeasts and filamentous fungi ( Korhonen and Pihlanto, 2007b ).
Lactoferricin is an amphipathic, cationic peptide with anti-microbial ( Wakabayashi , 2003 ) and anti-cancer ( Eliassen , 2002 ) properties. Lactoferricin can be generated by the pepsin-mediated digestion of lactoferrin. The MilkAMP database contains a total of 111 peptides (natural, synthetic and modified) comprising or derived from the complete lactoferricin ( Théolier , 2013 ), which displays anti-microbial and anti-carcinogenic functions.
Lactenin may have been the first antibacterial factor found in milk, which has been released from rennet hydrolysis of milk ( Jones and Simms, 1930 ). Casecidins are a group of basic, glycosylated and high molecular weight (about 5 kDa) polypeptides, which possess bactericidal properties against lactobacilli and also against various pathogenic bacteria such as Staphylococcus aureus . Isracidin is another antibacterial peptide derived from α s1 -CN, which is hydrolyzed with chymosin ( Hill , 1974 ).
- Immunomodulatory peptides
Peptides and protein hydrolysates generated from milk caseins and major whey proteins exert immunomodulatory effects [possess immune cell functions], including lymphocyte proliferation, antibody synthesis, and cytokine regulation ( Gill , 2000 ). Casein derived peptides are produced during fermentation of milk by lactic acid bacteria. These peptides have become special interest to food researchers and food processing industry due to their immune cell functions. These immunomodulatory peptides have been shown to modulate the proliferation of human lymphocytes, to stimulate the phagocytic activities of macrophages, and to down-regulate the production of certain cytokines (Korhonen and Pihlanto, 2003, 2007 ; Matar , 2003 ). Immunomodulatory peptides generated from milk include α s1 -CN f194-199 (α s1 -immunocasokinin) and β-CN f193-202, f63-68, f191-193 (immunopeptides), which are synthesized by hydrolysis with pepsin-chymosin.
The proliferation of human colonic lamina propria lymphocytes was inhibited by immunomodulatory effect of β-casomorphin-7, where the antiproliferative effect of micromolar concentrations was reversed by the opiate receptor antagonist naloxone ( Elitsur and Luk, 1991 ). Free amino acid glutamine can be substituted by glutamine-containing peptides, where glutamine is required for lymphocyte proliferation, and it is also utilized at a high rate by immunocompetent cells for the immunomodulatory effect ( Calder, 1994 ).
- Cytomodulatory peptides
Peptides derived from caseins can modulate cell viability such as proliferation and apoptosis in different human cell cultures, inhibit cancer cell growth or stimulate the activity of immunocompetent cells and neonatal intestinal cells ( Hartmann , 2000 ). Peptides derived from milk act as specific signals that may trigger viability of cancer cells ( Gobbettti , 2007 ).
Casein hydrolysis by bacteria using commercial yogurt starter cultures can yield bioactive peptides which affect colon cell Caco-2 kinetics in vitro . Roy (1999) also found that skim cow milk digested with cell-free extract of the yeast Saccharomyces cerevisiae showed antiproliferative activity towards leukemia cells.
Caseinophosphopeptides (CPPs) have also been reported to exhibit cytomodulatory effects. Cytomodulatory peptides obtained from casein fractions can inhibit cancer cell growth or stimulate the activity of immunocompetent cells and neonatal intestinal cells ( Meisel and FitzGerald, 2003 ). Gobbetti (2007) reported that peptides released from a lyophilized extract of Gouda cheese inhibited proliferation of leukemia cells.
- Mineral binding peptides
Mineral-binding phosphopeptides or caseinophosphopeptides (CCPs) have the function of carriers for different minerals by forming soluble organophosphate salts, especially Ca++ ion; About 1 mol of CPP can bind 40 mol of Ca 2+ ( Meisel and Olieman, 1998 ; Schlimme and Meisel, 1995 ). The α s1 -, α s2 - and β-CN of cow milk contain phosphorylated regions which can be released by digestive enzymes. Specific CPPs can form soluble organophosphate salt and increase Ca absorption by limiting Ca precipitation in the ileum ( Korhonen and Pihlanto, 2007b ).
Most CPPs contain a common motif, such as a sequence of three phosphoseryl followed by two glutamic acid residues ( Gobbetti , 2007 ). The negatively charged side chains, particularly the phosphate groups, of these amino acids of CPPs become the specific binding sites for minerals ( Gobbetti , 2007 ). Chemical phosphorylation of α s1 - and β-CN increased the binding capacity and the stability of these proteins in the presence of Ca 2+ ( Yoshikawa , 1981 ).
- Growth factors
Milk growth factor [MGF] is a peptide having the complete N-terminal sequence homologous to bovine TGF-β2.MGF suppresses in vitro proliferation of human T-cells, which includes proliferation induced by mitogen, IL-2 and exposure of primed cells to tetanus toxoid antigen ( Stoeck , 1989 ). Many growth factors in milk have been identified, such as insulin-like growth factor, platelet-derived growth factor, epidermal growth factor, and transforming growth factor; lactulose from lactose, nucleotides, somatotropin for bifidus growth ( Grosnvenor , 1992 ; Park, 2009a ).
Human milk contains physiologically active levels of growth factor, whereas bovine milk has much lower levels of growth factor activity ( Grosvenor , 1992 ; Wu and Elsasser, 1995 ). Colostrum of most mammals usually contains high concentrations of growth factors and others bioactive compounds, while the high levels of these growth factor compounds drop rapidly during the first 3 d postpartum ( Brown and Blakeley, 1984 ; Denhard , 2000 ). Goat milk is shown to be a great source of physiologically active growth factors ( Wu and Elsasser, 1995 ).
Unlike bovine milk, human milk contains a growth-promoting activity for Lactobacillus bifidus var. Pennsylvanicus ( Gyorgy , 1974 ), which is responsible for the predominance of Lactobacillus in the bacterial flora of large intestines of breast-fed infants. Caprine milk has yet to be studied in this premise. The bifidus growth-factor activity is attributed to N-containing oligosaccharides ( Gyorgy , 1974 ) and glycopeptides and glycoproteins ( Bezkorovainy , 1979 ). The oligosaccharide moiety of those molecules may possess the bifidobacterium growth-promoter activity which is associated with caseins ( Bezkorvainy and Topouzian, 1981 ).
Bioactive Peptides Uniquely Derived from Whey Proteins
There are many bioactive peptides derived from whey proteins. Some of the known bioactive peptides obtained from whey proteins include α-lactorphin, β-lactorphin, β-lactotensin, serorphin, albutensin A and lactoferricin ( Table 3 ). Some whey proteins are known to contain bioactive peptides with weak opioid activity, including serorphin, albutensin from serum albumin fraction, lactoferroxin from lactoferrin and lactotensin from β-lactoglobulin ( Shah, 2000 ; Tani , 1994 ).
Bioactive peptides derived from whey proteins
PPT Slide
Lager Image
Adapted from Korhonen et al. (1998).
It was found that minor whey proteins such as lactoferrin, lysozyme, lactoperoxidase and immunoglobulins are believed to be antimicrobial proteins. These whey proteins generate bioactive peptides. Lactoferrin is a dominant whey protein in human milk and plays an important role in iron uptake in the intestine ( Hutchens , 1994 ; Vilgoen, 1995 ). Bovine lactoferrin is homologous to human lactoferrin. Bovine colostrum and milk contain about 1.5-5 mg/mL and 0.1 mg/mL, respectively.
Lactoferricin is a simple peptide consisting of 25 amino acid residues. A similar active peptide consisting of 47 amino acid residues has been obtained from human lactoferrin. The lactoferrin molecule is folded into two globular units, where each one is capable of binding one ferric (Fe +3 ) ion ( Shah, 2000 ).
Conclusions
Bovine milk and colostrum have been shown to be highly important source of natural bioactive components for human nutrition and health. Bioactive peptides are liberated during gastrointestinal digestion and fermentation of food materials by lactic acid bacteria. Research have proven that these peptides exhibit a wide variety of physiological functionalities, including antimicrobial, antihypertensive, antithrombotic, antioxidative, opioid, anti-appetizing, immunomodulatory, mineral-binding and growth promoting activities.
The myriad of innate bioactive peptides and biologically and physiologically active milk compounds from casein, whey proteins and other components in milk have been discovered. They present an excellent source of natural ingredients for different applications in functional foods. Industrial or semi-industrial scale processing techniques are available for fractionation and isolation of major proteins from colostrum and milk. In the near future, several break-through products based on these ingredients will be launched on worldwide markets. These bioactive peptides and milk components could be targeted to the development of functional food products for infants, elderly and immune-compromised people as well as to improve performance and prevent diet-related chronic diseases.
References
Bezkorovainy A. , Grohlich D. , Nichols J. H. 1979 Isolation of a glycopeptide fraction with Lactobacillus bifidus subspecies Pennsylvanicus growth-promoting activity from whole human milk casein Am. J. Clin. Nutr. 32 1428 - 1432
Bezkorovainy A. , Topouzian N. 1981 Bifidobacteriumbifidus var. Pennsylvanicus growth promoting activity of human milk casein and its derivatives Int. J. Biochem. 13 585 - 590    DOI : 10.1016/0020-711X(81)90184-1
Bounous G. , Gold P. 1991 The biological activity of undenatured dietary whey proteins: Role of glutathione Clin. Invest. Med. 14 296 - 309
Brown K. D. , Blakeley D. M. 1984 Partial purification and characterization of a growth factor present in goat’s colostrum Biochem. J. 219 609 - 617    DOI : 10.1042/bj2190609
Byun H.-G. , Lee J. K. , Park H. G. , Jeon J.-K. , Kim S.-K. 2009 Antioxidant peptides isolated from the marine rotifer, Brachionus rotundiformis Process Biochem. 44 842 - 846    DOI : 10.1016/j.procbio.2009.04.003
Calder P. C. 1994 Glutamine and the immune system Clin. Nutr. 13 2 - 8
Chabance B. , Marteau P. , Rambaud J. C. , Migliore-Samour D. , Jolles P. , Boynard M. , Perrotin P. , Buillet R. , Fiat A. M. 1998 Casein peptided release and passage to the blood in humans during digestion of milk or yogurt Biochimie 80 155 - 165    DOI : 10.1016/S0300-9084(98)80022-9
Clare D. A. , Catignani G. L. , Swaisgood H. E. 2003 Biodefense properties of milk: the role of antimicrobial proteins and peptides Curr. Pharm. Des. 9 1239 - 1255    DOI : 10.2174/1381612033454874
Clare D. A. , Swaisgood H. E. 2000 Bioactive milk peptides: A prospectus J. Dairy Sci. 83 1187 - 1195    DOI : 10.3168/jds.S0022-0302(00)74983-6
Denhard M. , Claus R. , Munz O. , Weiler U. 2000 Course of epidermal growth factor (EGF) and insulin-like growth factor (IFG-I) in mammary secretions of the goat during endpregnancy and early lactation J. Vet. Med. Ser. A 47 533 - 540    DOI : 10.1046/j.1439-0442.2000.00315.x
Eliassen L. T. , Berge G. , Sveinbjornsson B. , Svendsen J. S. , Vorland L. H. , Rekdal O. 2002 Evidence for a direct antitumor mechanism of action of Bovine lactoferricin Anticancer Res. 22 2703 - 2710
Elitsur Y. , Luk G. D. 1991 β-casomorphin (BCM) and human colonic lamina proprialymphocyte proliferation Clin. Exp. Immunol. 85 493 - 497
Fiat A. M. , Miglilore-Samour D. , Jolles P. , Crouet L. , Collier C. , Caen J. 1993 Biologicallyactive peptides from milk proteins with emphasis on two example concerning antithrombotic and immuno-modulating activities J. Dairy Sci. 76 301 - 310    DOI : 10.3168/jds.S0022-0302(93)77351-8
FitzGerald R. J. , Meisel H. 2000 Milk protein derived peptide inhibitors of angiotensin-I converting enzyme Brit. J. Nutr. 84 S33 - S37
FitzGerald R. J. , Meisel H. , Fox P. F. , McSweeney P. L. H. 2003 Advances in Dairy Chemistry 3rd ed Kluwer Academic/Plenum Publishers NY Milk protein hydrolysates and bioactive peptides 675 - 698
FitzGerald R. J. , Murray B. A. , Walsh D. J. 2004 Hypotensive peptides from milk proteins J. Nutr. 134 980S - 988S
Gill H. S. , Coull F. , Rutherfurd K. J. , Cross M. L. 2000 Immunoregulatory peptides in bovine milk Br. J. Nutr. 84 S111 - S117
Gobbetti M. , Minervini F. , Rizzello C. G. 2004 Angiotensin I-converting enzyme inhibitory and antimicrobial bioactive peptides Int. J. Dairy Technol. 57 173 - 188    DOI : 10.1111/j.1471-0307.2004.00139.x
Gobbetti M. , Minervini F. , Rizzello C. G. , Hui Y. H. 2007 Handbook of food products manufacturing John Wiley & Sons, Inc. Bioactive peptides in dairy products 489 - 517
Goldman A. S. , Goldblum R. M. , Jensen R. 1995 Handbook of Milk Composition Academic Press NY Defense agents in milk: A defense agents in human milk 727 - 748
Grosvenor C. E. , Picciano M. F. , Baumrucker C. R. 1992 Hormones and growth factors in milk Endocr. Rev. 14 710 - 728
Gyorgy P. , Jeanloz R. W. , Von Nicolai H. , Zilliken F. 1974 Undialyzable growth factors for Lactobacillus bifidus var. Pennsylvanicus Eur. J. Biochem. 43 29 - 33    DOI : 10.1111/j.1432-1033.1974.tb03380.x
Haenlein G. F. W. , Caccese R. , Haenlein G. F. W. , Ace D. L. 1984 Extension Goat Handbook USDA Publication Washington, D.C., E-1 Goat milk versus cow milk 1 - 4
Hartmann R. , Gunther S. , Martin D. , Meisel H. , Pentzien A. K. , Schlimme E. , Scholz N. 2000 Cytochemical model systems for the detection and characterization of potentially bioactive milk components Kieler Milchwirtschaftliche Forschungsberichte 52 61 - 85
Hartmann R. , Meisel H. 2007 Food-derivedpeptides with biological activity: from research to food applications Curr. Opin. Biotech. 18 1 - 7    DOI : 10.1016/j.copbio.2007.01.009
Hill R. D. , Lahov E. , Givol D. 1974 A rennin-sensitive bond in alpha and beta casein J. Dairy Res. 41 147 - 153    DOI : 10.1017/S0022029900015028
Hutchens T. W. , Rumball S. V. , Lonnerdal B. 1994 Lactoferrin: structure and function Adv. Exp. Med. Biol. 357 1 - 298
Iwami K. , Sakakibara K. , Ibuki F. 1986 Involvement of post-digestion hydrophobic peptides in plasma cholesterol-lowering effect of dietary plant protein Agri. Bio. Chem. 50 1217 - 1222    DOI : 10.1271/bbb1961.50.1217
Jolles P. , Levy-Toledano S. , Fiat A. M. , Soria C. , Gillesen D. , Thomaidis A. , Dunn F. W. , Caen J. 1986 Analogy between fibrinogen and casein: effect of an undecapeptide isolated from k-casein on platelet function Eur. J. Biochem. 158 379 - 382    DOI : 10.1111/j.1432-1033.1986.tb09764.x
Jones F. S. , Simms H. S. 1930 The bacterial growth inhibitor (lactenin) of milk J. Exp. Med. 51 327 - 339    DOI : 10.1084/jem.51.2.327
Kitts D. D. , Weiler K. 2003 Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery Curr. Pharm. Des. 9 1309 - 1323    DOI : 10.2174/1381612033454883
Korhonen H. , Marnila P. , Mine Y. , Shahidi S. 2006 Nutraceutical Proteins and Peptides in Health and Disease Taylor & Francis Group Boca Raton, F. L., USA Bovine milk antibodies for protection against microbial human diseases 137 - 159
Korhonen H. , Pihlanto-Leppala A. , Shortt C. , O’Brien J. 2004 Handbook of Functional Dairy Products CRC Press Boca Raton, F. L., USA Milk-derived bioactive peptides: formation and prospects for health promotion 109 - 124
Korhonen H. , Pihlanto-Leppala A. , Rantamaki P. , Tupasela T. 1998 The functional and biological properties of whey proteins: prospects for the development of functional foods Agri. Food Sci. Finland 7 283 - 296
Korhonen H. , Pihlanto A. 2007 Food-derived bioactive peptides - opportunities for designing future foods Curr. Pharm. Des. 9 1297 - 1308
Korhonen H. , Pihlanto A. , Hui Y. H. 2007 Handbook of food products manufacturing John Wiley & Sons, Inc. Bioactive peptides from food proteins 5 - 37
Korhonen H. , Pihlanto-Leppala A. , Shortt C. , O’Brien J. 2004 Handbook of functional dairy products CRC Press Boca Raton, F. L., USA Milk-derived bioactive peptides: Formation and prospects for health promotion 109 - 124
Krissansen G. W. 2007 Emerging health properties of whey proteins and their clinical implications J. Amer. College Nutr. 26 713S - 723S    DOI : 10.1080/07315724.2007.10719652
Li G. , Le G. , Shi Y. , Shrestha S. 2004 Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects Nutr. Res. 24 469 - 486    DOI : 10.1016/S0271-5317(04)00058-2
Matar C. , LeBlanc J. G. , Martin L. , Perdigon G. , Farnworth ER 2003 Handbook of Fermented Functional Foods. Functional Foods and Nutraceuticals series CRC Press Boca Raton, F. L., USA Active peptides released in fermented milk: role and functions 177 - 201
Meisel H. 1998 Overview on milk protein-derived peptides Inter. Dairy J. 8 363 - 373    DOI : 10.1016/S0958-6946(98)00059-4
Meisel H. , FitzGerald R. J. 2000 Opioid peptides encrypted in intact milk protein sequences Br. J. Nutr. 84 27 - 31
Meisel H. , FitzGerald R. J. 2003 Biofunctional peptides From milk proteins: mineral binding andcytomodulatory effects Curr. Pharm. Des. 9 1289 - 1295    DOI : 10.2174/1381612033454847
Meisel H. , Olieman C. 1998 Estimation of calcium-binding constants of casein phosphopeptides by capillary zone electrophoresis Analytica Chimica Acta 372 291 - 297    DOI : 10.1016/S0003-2670(98)00335-3
Meisel H. , Schlimme E. , Brantl V. , Teschemacher H. 1994 κ-casomorphins and related peptides: recent developments VCH Weinheim Inhibitors of angiotensin-converting enzyme derived from bovine casein (casokinins) 27 - 33
Meisel H. , Schlimme E. 1996 Bioacive peptides derived from milk proteins: ingredients for functional foods Kieler Milchwirtschaftliche Forschungsberichte 48 343 - 357
Nagaoka S. , Futamura Y. , Miwa K. , Takako A. , Yamauchi K. , Kanamaru Y. , Tadashi K. , Kuwata T. 2001 Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin Biochem. Biophys Res. Commun. 281 11 - 17    DOI : 10.1006/bbrc.2001.4298
Park Y. W. 1990 Nutrient profiles of commercial goat milk cheeses manufactured in the United States J. Dairy Sci. 73 3059 - 3067    DOI : 10.3168/jds.S0022-0302(90)78993-X
Park Y. W. , Park Y. W. , Haenlein G. F. W. 2006 Handbook of Milk of Non-Bovine Mammals Blackwell Publishers Ames, Iowa and Oxford, England Goat milk - Chemistry and Nutrition 34 - 58
Park Y. W. , Park Y. W. 2009 Bioactive Components in Milk and Dairy Products Wiley-Blackwell Publishers Ames, Iowa and Oxford, England Bioactive components of goat milk 43 - 82
Park Y. W. , Park Y. W. 2009 Bioactive Components in Milk and Dairy Products Wiley-Blackwell Publishers Ames, Iowa and Oxford, England Overview of bioactive components in milk and dairy products 3 - 14
Park Y. W. , Juárez M. , Ramos M. , Haenlein G. F. W. 2007 Physicochemical characteristics of goat and sheep milk. Special Issue book on Goat milk and Sheep milk Small Ruminant Res. J. 68 88 - 113    DOI : 10.1016/j.smallrumres.2006.09.013
Petrillo E. W. , Ondetti M. A. 1982 Angiotensin converting enzyme inhibitors: Medicinal chemistry and biological actions Med. Res. Rev. 2 1 - 41    DOI : 10.1002/med.2610020103
Playne M. J. , Bennett L. E. , Smithers G. W. 2003 Functional dairy foods and ingredients Australian J. Dairy Technol. 58 242 - 264
Qian Z. Y. , Jolles P. , Migliore-Samour D. , Schoentgen F. , Fiat A. M. 1995 Sheep kappa-casein peptides inhibit platelet aggregation Biochim Biophys Acta 1244 411 - 417    DOI : 10.1016/0304-4165(95)00047-F
Regester G. O. , Smithers G. W. , Mitchell I. R. , McIntosh G. H. , Dionysius D. A. , Welch R. , Burns D. , Davis S. , Popay A. , Prosser C. 1997 Milk composition, production and biotechnology CAB International Bioactive factors in milk: Natural and induced 119 - 132
Rival S. G. , Boeriu C. G. , Wichers H. J. 2001 Caseins and casein hydrolysates. 2. Antioxidativeproperties and relevance to lipoxygenase inhibition J. Agr. Food Chem. 4 295 - 302
Rokka T. , Syvoja E. L. , Tuominen J. , Korhonen H. 1997 Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk Milchwissenschaft 52 675 - 678
Roy M. K. , Watanabe Y. , Tamai Y. 1999 Induction of apoptosis in HL-60 cells by skimmed milk digested with a proteolytic enzyme from the yeast Saccharomyces cerevisiae J. Biosci. Bioeng. 88 426 - 432    DOI : 10.1016/S1389-1723(99)80221-7
Schanbacher F. L. , Talhouk R. S. , Murray F. A. , Gherman L. I. , Willet L. B. 1998 Milk-born bioactive peptides Int. Dairy J. 8 393 - 403    DOI : 10.1016/S0958-6946(98)00062-4
Schlimme E. , Meisel H. 1995 Bioactive peptides derived from milk proteins. Structural, physiological, and analytical aspects Die Nahrung 39 1 - 20    DOI : 10.1002/food.19950390102
Shah N. P. 2000 Effects of milk-derived bioactives: an overview Brit. J. Nutr. 84 S3 - S10
Stoeck M. , Ruegg C. , Miescher S. , Carrel S. , Cox D. , Von Fliedner V. , Alkan S. 1989 Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2 J. Immunol. 143 3258 - 3265
Suetsuna R. , Ukeda H. , Ochi H. 2000 Isolation and characterization of free radical scavenging activities peptides derived from casein J. Nutr. Biochem. 11 128 - 131    DOI : 10.1016/S0955-2863(99)00083-2
Tani F. , Shiiota A. , Chiba H. , Yoshikawa M. , Brandtl V. , Teschemacher H. 1994 β-Casomorphins and Related Peptides: Recent Developments VCH Germany Saerorphin, and opioid peptide derived from bovine serum albumin
Théolier J. , Fliss I. , Jean J. , Hammami R. 2013 Milk AMP: a comprehensive database of antimicrobial peptides of dairy origin Dairy Sci. Technol. 94 181 - 193
Viljoen M. 1995 Lactoferrin: a general review Haematologica 80 252 - 267
Wakabayashi H. , Takase M. , Tomita M. 2003 Lactoferricin derived from milk proteinlactoferrin Curr. Pharm. Des. 9 1277 - 1287    DOI : 10.2174/1381612033454829
Wilson Md. , Rudel L. L. 1994 Review of cholesterol absorption with emphasis on dietary and biliary cholesterol J. Lipid Res. 35 943 - 955
Wu F. Y. , Elsasser T. H. 1995 Studies on cell growth promoting activity in goat milk J. Chinese Agric. Chem. Soc. 33 326 - 332
Yoshikawa M. , Sasaki R. , Chiba H. 1981 Effect of chemical phosphorylation of bovine casein components on the properties related to casein micelle formation Agr. Bio. Chem. 45 909 - 914    DOI : 10.1271/bbb1961.45.909
Zhang X. , Beynen A. 1993 Lowering effect of dietary milk-whey protein v. casein on plasmaand liver cholesterol concentrations in rats Brit. J. Nutr. 70 139 - 146    DOI : 10.1079/BJN19930111